Myasthenia Gravis

"Myasthenia Gravis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed against acetylcholine receptors damage the motor endplate portion of the NEUROMUSCULAR JUNCTION, impairing the transmission of impulses to skeletal muscles. Clinical manifestations may include diplopia, ptosis, and weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles. THYMOMA is commonly associated with this condition. (Adams et al., Principles of Neurology, 6th ed, p1459)

Descriptor ID	D009157
MeSH Number(s)	C10.114.656 C10.668.758.725 C20.111.258.500
Concept/Terms	Myasthenia Gravis Myasthenia Gravis Myasthenia Gravis, Ocular Myasthenia Gravis, Ocular Ocular Myasthenia Gravis Myasthenia Gravis, Generalized Myasthenia Gravis, Generalized Generalized Myasthenia Gravis

Below are MeSH descriptors whose meaning is more general than "Myasthenia Gravis".

Diseases [C]
Nervous System Diseases [C10]
Autoimmune Diseases of the Nervous System [C10.114]
Myasthenia Gravis [C10.114.656]
Neuromuscular Diseases [C10.668]
Neuromuscular Junction Diseases [C10.668.758]
Myasthenia Gravis [C10.668.758.725]
Immune System Diseases [C20]
Autoimmune Diseases [C20.111]
Autoimmune Diseases of the Nervous System [C20.111.258]
Myasthenia Gravis [C20.111.258.500]

Below are MeSH descriptors whose meaning is related to "Myasthenia Gravis".

Below are MeSH descriptors whose meaning is more specific than "Myasthenia Gravis".

Myasthenia Gravis
Myasthenia Gravis, Autoimmune, Experimental
Myasthenia Gravis, Neonatal

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Myasthenia Gravis" by people in this website by year, and whether "Myasthenia Gravis" was a major or minor topic of these publications.

Bar chart showing 9 publications over 8 distinct years, with a maximum of 2 publications in 2026

To see the data from this visualization as text, click here.

Year	Major Topic	Total
2005	1	1
2010	1	1
2014	1	1
2016	1	1
2018	1	1
2020	1	1
2024	1	1
2026	2	2

Below are the most recent publications written about "Myasthenia Gravis" by people in Profiles.

Lanni J, Bose A, Cachia D. Outcomes in checkpoint inhibitor induced neuromuscular immune related adverse events: A case series. J Neuroimmunol. 2026 Sep; 418:578986.

View in: PubMed
Kwon S, Park YB, Han KD, Chung YH, Cho EB, Shin DW, Min JH. Association between obesity and subsequent risk of myasthenia gravis: a nationwide population-based cohort study. Acta Neurol Belg. 2026 Jun; 126(3):1095-1103.

View in: PubMed
D'Ambrosio ES, Allen MD, Ozes B, Sahenk Z. Concurrent nodular lymphocytic myositis and myasthenia gravis. A case report. Neuromuscul Disord. 2024 Dec; 45:105211.

View in: PubMed
?ebi M, Durmus H, Aysal F, ?zkan B, G?l GE, ?akar A, Hocaoglu M, Mercan M, Yent?r SP, T?t?nc? M, Yayla V, Akan O, Dogan ?, Parman Y, Saruhan-Direskeneli G. CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS. Front Immunol. 2020; 11:809.

View in: PubMed
Hocaoglu M, Durmus H, ?zkan B, Yent?r SP, Dogan ?, Parman Y, Deymeer F, Saruhan-Direskeneli G. Increased costimulatory molecule expression of thymic and peripheral B cells and a sensitivity to IL-21 in myasthenia gravis. J Neuroimmunol. 2018 10 15; 323:36-42.

View in: PubMed
Shenoy AM. Registry Participation in Neuromuscular Disease. Continuum (Minneap Minn). 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):2012-2014.

View in: PubMed
Murray MJ, DeBlock H, Erstad B, Gray A, Jacobi J, Jordan C, McGee W, McManus C, Meade M, Nix S, Patterson A, Sands MK, Pino R, Tescher A, Arbour R, Rochwerg B, Murray CF, Mehta S. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient. Crit Care Med. 2016 Nov; 44(11):2079-2103.

View in: PubMed
Sun F, Ladha SS, Yang L, Liu Q, Shi SX, Su N, Bomprezzi R, Shi FD. Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis. Muscle Nerve. 2014 Apr; 49(4):487-94.

View in: PubMed
Chhibber V, Weinstein R. Evidence-based review of therapeutic plasma exchange in neurological disorders. Semin Dial. 2012 Mar-Apr; 25(2):132-9.

View in: PubMed
Peltier AC, Black BK, Raj SR, Donofrio P, Robertson D, Biaggioni I. Coexistent autoimmune autonomic ganglionopathy and myasthenia gravis associated with non-small-cell lung cancer. Muscle Nerve. 2010 Mar; 41(3):416-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals